Parantar, Rosita G.

HRN: 12-21-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/31/2026
02/07/2026
IV
2.25
Q6
CAP HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: